KAYLA DAVIS: Open Payments
NPI 1023749140 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 11 payments from 6 companies in 2025. Trend: 2023 $155 · 2024 $830 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $208 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $136 |
| United Therapeutics Corporation | 1 | $128 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Grifols USA, LLC | 1 | $29 |
| Lilly USA, LLC | 1 | $22 |
Products named: FASENRA, OFEV, NUCALA, TEZSPIRE, Prolastin-C Liquid.
Industry payments across WI — which companies pay providers there.
